TY - JOUR
T1 - Enhancing the Trustworthiness of the Endocrine Society's Clinical Practice Guidelines
AU - McCartney, Christopher R.
AU - Corrigan, Maureen D.
AU - Drake, Matthew T.
AU - El-Hajj Fuleihan, Ghada
AU - Korytkowski, Mary T.
AU - Lash, Robert W.
AU - Lieb, David C.
AU - McCall, Anthony L.
AU - Muniyappa, Ranganath
AU - Piggott, Thomas
AU - Santesso, Nancy
AU - Schünemann, Holger J.
AU - Wiercioch, Wojtek
AU - McDonnell, Marie E.
AU - Murad, M. Hassan
N1 - Publisher Copyright:
© The Author(s) 2022.
PY - 2022/8/1
Y1 - 2022/8/1
N2 - In an effort to enhance the trustworthiness of its clinical practice guidelines, the Endocrine Society has recently adopted new policies and more rigorous methodologies for its guideline program. In this Clinical Practice Guideline Communication, we describe these recent enhancements-many of which reflect greater adherence to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to guideline development-in addition to the rationale for such changes. Improvements to the Society's guideline development practices include, but are not limited to, enhanced inclusion of nonendocrinologist experts, including patient representatives, on guideline development panels; implementation of a more rigorous conflict/duality of interest policy; a requirement that all formal recommendations must be demonstrably underpinned by systematic evidence review; the explicit use of GRADE Evidence-to-Decision frameworks; greater use and explanation of standardized guideline language; and a more intentional approach to guideline updating. Lastly, we describe some of the experiential differences our guideline readers are most likely to notice.
AB - In an effort to enhance the trustworthiness of its clinical practice guidelines, the Endocrine Society has recently adopted new policies and more rigorous methodologies for its guideline program. In this Clinical Practice Guideline Communication, we describe these recent enhancements-many of which reflect greater adherence to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach to guideline development-in addition to the rationale for such changes. Improvements to the Society's guideline development practices include, but are not limited to, enhanced inclusion of nonendocrinologist experts, including patient representatives, on guideline development panels; implementation of a more rigorous conflict/duality of interest policy; a requirement that all formal recommendations must be demonstrably underpinned by systematic evidence review; the explicit use of GRADE Evidence-to-Decision frameworks; greater use and explanation of standardized guideline language; and a more intentional approach to guideline updating. Lastly, we describe some of the experiential differences our guideline readers are most likely to notice.
KW - GRADE approach
KW - clinical practice guidelines
KW - practice guidelines
KW - systematic reviews
KW - trust
KW - trustworthiness
UR - http://www.scopus.com/inward/record.url?scp=85134429189&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85134429189&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgac290
DO - 10.1210/clinem/dgac290
M3 - Article
C2 - 35690966
AN - SCOPUS:85134429189
SN - 0021-972X
VL - 107
SP - 2129
EP - 2138
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 8
ER -